Search:

< Go Back

Drug Discovery Technologies - A Global Market Overview
Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014
Sierk Pötting to be the New CFO (Chief Financial Officer) of BioNTech Group
New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
CannaMed Announces Name Change and Trading Symbol Change
Implementing a Strategic Thought Leader Management & Engagement System
Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector
Mast Therapeutics Announces Management Change
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
Amaranth Seed Oil Market worth $700.6 Million by 2019
US CNS Disorders Drug Pipeline Insight 2014
Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark
District Court Decision Received In Remodulin Patent Case
Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018
Vaccines at the Crossroads: Outbreaks On the Rise Across America
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs
Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission
Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical
DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments
CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. English
Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020
Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches
TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF)
Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS
New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications
Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company
The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT
Ebola vaccine trials fast-tracked by international consortium
Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit
September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic
Seres Health to Present Clinical Findings at ICAAC 2014 Conference
Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
Rx Safes, Inc. Announces New War On Drugs
4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner
Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA
Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support
GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids
Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine
CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years
EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro® RC System DM2 ENABLE Study
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile

< Prev Next >
PR Newswire - United Business Media